GHK-Cu Copper Peptide · Research brief

GHK-Cu vs AHK-Cu for Hair Growth: What Studies Report

Real Peptides Research TeamEditorial

Updated September 30, 20269 min read

57 WORDS

Short answer

Swap a single amino acid and the research story changes completely. GHK-Cu and AHK-Cu are both copper-complexed tripeptides, both blue-violet in solution, both research-use-only compounds, and both routinely bundled into the same product marketing. The peer-reviewed literature behind them is nowhere near equal in size, and the follicle models they appear in are not the same models.

Key takeaways

GHK-Cu and AHK-Cu differ by one amino acid, glycine versus alanine, and both coordinate copper(II) through a histidine imidazole nitrogen in a 1:1 complex.
GHK-Cu has the larger peer-reviewed literature overall, while AHK-Cu's much smaller literature is more specifically focused on cultured dermal papilla cells.
Scalp anagen lasts roughly two to seven years and hair grows around one centimetre per month, so no short in vitro assay can predict a human hair outcome.
Increased dermal papilla proliferation in cell culture is a mechanistic signal, not documented regrowth, and conflating the two is the most common error in copper-peptide content.
Copper peptides lose integrity through reduction, chelator competition and hostile surfactant bases, and a colour shift away from blue-violet is the clearest visible warning sign.
Both compounds are research-use-only materials that should be purchased with a certificate of analysis confirming identity and purity by HPLC and mass spectrometry.

We supply both compounds to laboratories, and this comparison lands in our inbox more often than any other copper-peptide question. Our team sees researchers choose the wrong format for their assay about as often as they choose the wrong molecule.

GHK Cu vs AHK Cu for hair growth: which one does the published research support?

GHK-Cu (glycyl-L-histidyl-L-lysine copper) carries by far the larger body of peer-reviewed work, most of it concerning extracellular matrix repair and skin remodelling rather than hair specifically. AHK-Cu (alanyl-L-histidyl-L-lysine copper) appears in a much smaller set of in vitro dermal papilla studies. Neither is an approved hair-loss drug.

The over-simplification worth dropping first is the idea that one is the skin peptide and the other is the hair peptide. Both are copper-delivery molecules built around a histidine-lysine motif, and the coordinated copper ion does much of the biochemical work described in the literature, not the peptide backbone alone. Searches for GHK Cu vs AHK Cu for hair growth usually want a winner declared. What follows instead is how the two molecules differ structurally, what follicle research models actually measure, why formulation chemistry destroys more copper peptide than biology ever does, and where the evidence honestly runs out.

Two tripeptides, one shared histidine, different backbones

GHK is glycine-histidine-lysine. AHK is alanine-histidine-lysine. That single substitution is the entire structural difference between the two molecules, and it is not trivial: glycine has no side chain at all, while alanine adds a methyl group, which shifts hydrophobicity and the local charge environment around the copper-binding site.

In both peptides, copper(II) is coordinated largely through the imidazole nitrogen of the histidine residue together with backbone donor atoms, forming a 1:1 chelate. That chelation is the point of the molecule. Free copper ions are redox-active and pro-oxidant through Fenton-type chemistry, whereas copper held in a peptide complex is delivered in a buffered, far less reactive form. Strip the copper out and you no longer have a copper peptide. You have a tripeptide and a metal ion doing unrelated things.

This is why the two cannot be treated as interchangeable inputs in a research model. Binding affinity, solubility behaviour and cell-culture uptake all track back to that backbone difference. Researchers comparing ghk cu and ahk cu for hair models in the same assay should expect different concentration-response behaviour before they expect different biology.

What follicle research models actually measure

Most follicle work on copper peptides happens in cultured dermal papilla cells, the mesenchymal cell population sitting at the base of the hair follicle that governs cycling between growth and rest. Scalp anagen (the active growth phase) runs roughly two to seven years, telogen (rest) lasts around three months, and terminal scalp hair grows on the order of one centimetre per month. Those timescales matter, because nothing in a 72-hour cell-culture experiment can speak to them directly.

The endpoints these models report are proliferation rates, angiogenic signalling markers such as vascular endothelial growth factor (VEGF), and follicle elongation in organ culture. AHK-Cu's small published footprint sits mostly in that cell-culture space. GHK-Cu's much larger footprint sits mostly in dermal matrix and wound-repair biology, which touches the follicle indirectly through the perifollicular connective tissue and microvasculature that supply it.

Here is the interpretive error almost every write-up on ghk cu or ahk cu for hair growth makes: it treats increased dermal papilla proliferation as evidence of regrowth. It isn't. Proliferation in a dish is a mechanistic signal, not a scalp outcome, and the gap between the two is where most consumer claims quietly live. We won't quote hard figures from studies we can't point you to in an indexed database, and you should be suspicious of pages that do.

Formulation and storage decide whether either peptide survives

The practical failure point for both compounds is chemistry in the container, not biology in the tissue. Copper peptides are incompatible with strong reducing agents, including direct L-ascorbic acid, which can reduce Cu(II) and collapse the complex. Competing chelators such as EDTA pull copper away from the peptide. Heavily anionic surfactant systems are hostile territory too, which is why a ghk cu ahk cu shampoo is the least controlled format available: the base is aggressive and rinse-off contact time is measured in seconds.

Colour is the cheapest diagnostic available. That blue-violet tint comes from the copper complex itself, so a drift toward brown, green or colourless indicates the coordination chemistry has changed. A stable-looking ghk cu and ahk cu hair serum that has gone dull is telling you something the label won't.

For laboratory handling, lyophilised powder is held at around −20°C, protected from light, with aqueous solutions refrigerated at 2°C to 8°C and repeated freeze-thaw cycles avoided. Identity and purity are verified by HPLC and mass spectrometry, documented on the certificate of analysis. That documentation is why we run small-batch synthesis with exact sequence verification on both our GHK-Cu 50mg and AHK-Cu research vials. A peptide you can't characterise isn't a variable, it's noise.

GHK Cu vs AHK Cu for Hair Growth: A Research-Model Comparison

This table compares the two compounds on the factors that actually change a study design or a formulation decision. It deliberately avoids efficacy scores, because the published evidence does not support ranking them on human hair outcomes.

Factor	GHK-Cu (glycyl-histidyl-lysine copper)	AHK-Cu (alanyl-histidyl-lysine copper)	Bottom Line
Structure	Glycine at position one, no side chain, 1:1 copper chelate via histidine	Alanine at position one, adds a methyl group, same histidine coordination motif	One substitution changes hydrophobicity and binding behaviour, so results are not transferable between them
Size of published literature	Substantially larger, spanning matrix remodelling, tissue repair and gene-expression work	Small and narrow, concentrated in in vitro dermal papilla and follicle culture work	GHK-Cu is the better-characterised molecule; AHK-Cu is the more follicle-specific but far thinner one
Typical research endpoints	Collagen and glycosaminoglycan synthesis, fibroblast behaviour, wound-repair markers	Dermal papilla proliferation and angiogenic signalling such as VEGF expression	Endpoint mismatch is why head-to-head comparison requires one shared model, not two literatures
Formulation stability	Vulnerable to reducing agents, competing chelators and low-pH acid systems	Same vulnerabilities, same copper-loss mechanism	Neither survives a badly built base; the copper is the fragile part, not the peptide
Storage and handling	Lyophilised at roughly −20°C, solutions at 2 to 8°C, protect from light	Identical requirements	Handling discipline matters more to reproducibility than compound choice
Regulatory status	Research-use-only, not an FDA-approved drug for hair loss or any other indication	Research-use-only, not an FDA-approved drug for hair loss or any other indication	Any page presenting either as a treatment is describing marketing, not regulation

What If: Copper Peptide Research Scenarios

What if a GHK-Cu and AHK-Cu serum has changed colour?

Treat the material as chemically altered and stop using it as a defined research input. The blue-violet colour is a direct readout of intact copper coordination, so browning, greening or fading indicates the complex has been reduced, displaced or degraded. Any ghk cu and ahk cu serum formulated alongside direct acids, thiols or chelating agents is a prime candidate for this, and no home test can confirm what percentage of the copper is still peptide-bound. Colour tells you something changed. It cannot tell you what.

What if Reddit threads claim one peptide clearly beats the other?

Read them as hypothesis generators, not evidence. Threads searching ahk cu vs ghk cu hair reddit or ghk cu ahk cu hair serum reddit are full of confident conclusions drawn from uncontrolled, unblinded, single-person experiences with products of unverified concentration and unknown copper integrity. Hair cycles naturally over months, which makes seasonal shedding and regrowth trivially easy to misattribute. Our team has read enough of these threads to notice the pattern: the strongest claims almost always come from people who changed three variables at once.

What if a study needs to compare both peptides directly?

Run them in the same model, at matched molar concentrations, with copper content verified rather than assumed. The reason the ghk cu or ahk cu for hair loss question has no clean answer in the literature is that the two compounds were mostly studied in different systems with different endpoints, so cross-study comparison is structurally invalid. Matching on peptide mass rather than molar copper is a subtle design trap, since the molecular weights differ and copper delivery is the shared mechanism under examination.

What if the only available format is a rinse-off product?

Expect the weakest possible exposure conditions and plan the research question accordingly. A shampoo base combines high surfactant load, variable pH and contact time of under a minute, which is close to the worst-case scenario for maintaining a copper chelate and delivering it anywhere meaningful. Leave-on formats keep the complex in contact with tissue for far longer, which is one reason most published copper-peptide work uses controlled solutions rather than cleansing bases.

The Unglamorous Truth About Copper Peptides and Hair

Let's be direct about this: neither compound is an established hair-loss therapy, and the honest answer to ghk cu or ahk cu for hair loss is that the published evidence sits at the cell-culture and mechanism stage, not the large controlled-trial stage. GHK-Cu is better characterised. AHK-Cu is more follicle-specific. Neither fact makes either one a treatment, and both are supplied for laboratory research only, not for human or animal use. This article is educational and describes research context only. If the question concerns an animal's coat rather than a human scalp, talk to your veterinarian, and if it concerns your own hair loss, that is a conversation for a licensed physician.

If your work sits in this area, our hair and skin research collection groups the relevant compounds together, our GHK-Cu reference page covers the molecule in more depth, and every batch we ship has documentation available through our certificates of analysis. Researchers comparing options across related signalling compounds can browse the wider research catalog alongside them.

The framing of GHK Cu vs AHK Cu for hair growth as a contest is what keeps the question unanswerable. One molecule has breadth of evidence, the other has narrower relevance to the dermal papilla, and the variable most likely to decide what either one does in a given experiment isn't the amino acid at position one at all. It's whether the copper was still bound when the compound reached the cells. Get the chemistry documented first, and the comparison becomes a real question instead of a marketing argument.

References

Peer-reviewed sources on GHK-Cu indexed in PubMed, listed for research context. Real Peptides supplies GHK-Cu for laboratory research use only.

Topically applied GHK as an anti-wrinkle peptide: Advantages, problems and prospective. BioImpacts : BI, 2025. PMID 39963574. doi:10.34172/bi.30071
Copper Complexes with New Glycyl-l-histidyl-l-lysine-Hyaluronan Conjugates Show Antioxidant Properties and Osteogenic and Angiogenic Synergistic Effects. Bioconjugate chemistry, 2025. PMID 40123442. doi:10.1021/acs.bioconjchem.4c00545
Are We Ready to Measure Skin Permeation of Modern Antiaging GHK-Cu Tripeptide Encapsulated in Liposomes?. Molecules (Basel, Switzerland), 2025. PMID 39795193. doi:10.3390/molecules30010136
An injectable hydroxyapatite microsphere filler loaded with GHK-Cu tripeptide for anti-Inflammatory and antioxidant. Colloids and surfaces. B, Biointerfaces, 2025. PMID 40716276. doi:10.1016/j.colsurfb.2025.114982
The glycyl-l-histidyl-l-lysine-Cu(2+) tripeptide complex attenuates lung inflammation and fibrosis in silicosis by targeting peroxiredoxin 6. Redox biology, 2024. PMID 38879894. doi:10.1016/j.redox.2024.103237
Glycyl-l-histidyl-l-lysine-Cu(2+) rescues cigarette smoking-induced skeletal muscle dysfunction via a sirtuin 1-dependent pathway. Journal of cachexia, sarcopenia and muscle, 2023. PMID 36905132. doi:10.1002/jcsm.13213
Improved laccase production by Trametes versicolor using Copper-Glycyl-L-Histidyl-L-Lysine as a novel and high-efficient inducer. Frontiers in bioengineering and biotechnology, 2023. PMID 37180036. doi:10.3389/fbioe.2023.1176352
Ultrasensitive and Label-Free Detection of Copper Ions by GHK-Modified Asymmetric Nanochannels. Analytical chemistry, 2023. PMID 37624577. doi:10.1021/acs.analchem.3c01174

Build a pack

Researching more than one compound?

Build a multi-vial pack and the discount applies automatically as you add doses.

Start a pack

Questions

GHK-Cu has the substantially larger peer-reviewed literature, but most of it concerns extracellular matrix repair, fibroblast behaviour and tissue remodelling rather than hair follicles specifically. AHK-Cu's literature is much smaller and sits mainly in in vitro dermal papilla and follicle culture work, which makes it more topic-specific but far less extensive. Neither body of evidence establishes either compound as a hair-loss treatment.

No, and any page that declares one is overstating the evidence. The two compounds were studied in different models with different endpoints, so the results cannot be compared across studies in a scientifically valid way. A genuine comparison requires both peptides run in the same model at matched molar copper concentrations, which the published literature has not done at scale.

The standard approach uses cultured human dermal papilla cells or follicle organ culture, measuring proliferation, angiogenic markers such as VEGF expression, and follicle elongation. Both compounds are run in the same system at matched molar concentrations so that copper delivery, the shared mechanism, is held constant. Matching on peptide mass instead of molar copper is a common design error because the two molecules have different molecular weights.

Formulators typically pair them because the two peptides are marketed to different narratives, matrix repair for GHK-Cu and follicle signalling for AHK-Cu, so combining them broadens the marketing claim set. There is no strong published evidence that the combination outperforms either compound alone in a controlled model. A ghk cu and ahk cu hair serum is a formulation decision first and a research-supported one second.

Research-grade copper peptides are supplied for laboratory research use only and are not sold as drugs, cosmetics or supplements. Buyers are expected to be researchers or laboratories using the material in vitro, and reputable suppliers state this restriction explicitly on the product page. These compounds are not FDA-approved and are never intended for human or animal administration.

Cost is driven mainly by synthesis scale, vial quantity, verified purity and whether full analytical documentation is included. Peptides sold with HPLC and mass spectrometry results on a certificate of analysis generally cost more than undocumented material, because the testing is a real expense rather than a marketing line. Prices vary widely between suppliers, so comparing cost without comparing documentation is not a meaningful comparison.

Lyophilised copper peptide powder is typically held at around −20°C and protected from light, with aqueous solutions kept refrigerated at 2°C to 8°C. Repeated freeze-thaw cycling should be avoided because it stresses the complex and introduces variability between experiments. Temperature excursions can alter the material in ways that appearance alone will not always reveal.

The blue-to-violet colour comes from the copper(II) ion held in the peptide complex, so a shift toward brown, green or colourless signals that the coordination chemistry has changed. Common causes include reducing agents such as direct L-ascorbic acid, competing chelators like EDTA, low pH and prolonged light or heat exposure. Once the colour has shifted, the material should no longer be treated as a defined research input.

A rinse-off format is the least favourable environment for either peptide. Shampoo bases combine high anionic surfactant load with variable pH and a contact time usually under a minute, which works against maintaining an intact copper chelate. Most published copper-peptide research uses controlled leave-on solutions precisely because exposure conditions can be defined and held constant.

Threads searching ahk cu vs ghk cu hair reddit tend to draw firm conclusions from uncontrolled single-person experiences using products of unknown concentration and unverified copper integrity. Hair naturally cycles over months, so seasonal shedding and spontaneous regrowth are easy to misattribute to whatever was applied at the time. Those reports can generate hypotheses, but they cannot substitute for controlled research.

No. Neither GHK-Cu nor AHK-Cu is an FDA-approved drug for hair loss or any other indication, and both are supplied as research-use-only compounds. Approved pharmacological options for pattern hair loss exist and are a matter for a licensed physician, not a research-chemical purchase decision.

GHK is glycine-histidine-lysine and AHK is alanine-histidine-lysine, so the only difference is the first residue: glycine has no side chain while alanine carries a methyl group. Both coordinate copper(II) largely through the histidine imidazole nitrogen in a 1:1 complex. That single substitution alters hydrophobicity and binding behaviour enough that results from one compound should not be assumed to apply to the other.

RESEARCH USE ONLY · NOT EVALUATED BY THE FDA